Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS™)

被引:64
作者
Edwards, AD
Shekunov, BY [1 ]
Kordikowski, A
Forbes, RT
York, P
机构
[1] Univ Bradford, Sch Pharm, Drug Delivery Grp, Bradford BD7 1DP, W Yorkshire, England
[2] BPD PLC, Bradford BD7 1HR, W Yorkshire, England
关键词
crystallization; SEDS; dispersion; polymorphism;
D O I
10.1002/jps.1065
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pure anhydrous polymorphs of carbamazepine were prepared by solution-enhanced dispersion with supercritical fluids (SEDS (TM)). Crystallization of the polymorphs was studied. Mechanisms are proposed that consider the thermodynamics of carbamazepine, supersaturation in the SEDS (TM) process, and the binary phase equilibria of organic solvents and the carbon dioxide antisolvent. alpha -Carbamazepine was crystallized at high supersaturations and low temperatures, beta -carbamazepine crystallized from a methanol-carbon dioxide phase split, and gamma -carbamazepine crystallized via nucleation at high temperatures and low supersaturation. (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association.
引用
收藏
页码:1115 / 1124
页数:10
相关论文
共 19 条
[1]   Control of the physical form of salmeterol xinofoate [J].
Beach, S ;
Latham, D ;
Sidgwick, C ;
Hanna, M ;
York, P .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (05) :370-376
[2]   HEAT OF FUSION MEASUREMENT OF A LOW MELTING POLYMORPH OF CARBAMAZEPINE THAT UNDERGOES MULTIPLE-PHASE CHANGES DURING DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS [J].
BEHME, RJ ;
BROOKE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) :986-990
[3]   Solubility analysis of drug compounds in supercritical carbon dioxide using static and dynamic extraction systems [J].
Bristow, S ;
Shekunov, BY ;
York, P .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2001, 40 (07) :1732-1739
[4]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[5]   X-ray characterization of the triclinic polymorph of carbamazepine [J].
Ceolin, R ;
Toscani, S ;
Gardette, MF ;
Agafonov, VN ;
Dzyabchenko, AV ;
Bachet, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1062-1065
[6]   Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine [J].
Edwards, AD ;
Shekunov, BY ;
Forbes, RT ;
Grossmann, JG ;
York, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (08) :1106-1114
[7]   THERMAL-ANALYSIS AND CALORIMETRIC METHODS IN THE CHARACTERIZATION OF POLYMORPHS AND SOLVATES [J].
GIRON, D .
THERMOCHIMICA ACTA, 1995, 248 :1-59
[8]  
Grant DJW, 1999, DRUGS PHARM SCI, V95, P1
[9]   PHARMACEUTICAL APPLICATIONS OF POLYMORPHISM [J].
HALEBLIAN, J ;
MCCRONE, W .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (08) :911-+
[10]  
JENNINGS DW, 1993, ACS SYM SER, V514, P10